NDC 60267-705
Sodium Thiosulfate 250 mg per 1 mL injection, solution
On the label: Hope Pharmaceuticals.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Bora Pharmaceuticals Injectables Inc. | Baltimore, MD, United States | Makes it | Problems found, fixed voluntarilyAug 10, 2023 · 12 inspections, 1 with FDA action |
| Curia New York, Inc. | Rensselaer, NY, United States | Makes the active ingredient | Serious problems, FDA actionFeb 5, 2026 · 8 inspections, 1 with FDA action |
| Pharmaceutics International, Inc. | Cockeysville, MD, United States | Makes it | Serious problems, FDA actionMar 6, 2026 · 10 inspections, 2 with FDA action |
| Siegfried Grafton, Inc. | Grafton, WI, United States | Makes the active ingredient | Problems found, fixed voluntarilyAug 21, 2026 · 7 inspections |
| Sterling Wisconsin, LLC | Germantown, WI, United States | Makes the active ingredient | No problems foundMar 12, 2024 · 6 inspections |
Product details
- Generic drug
- Thiosulfate Ion: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 250 mg per 1 mL
- Approval
- NDA NDA203923
- On the market since
- Feb 14, 2012
- Package NDCs
60267-705-50- Official label
- DailyMed (National Library of Medicine), updated May 26, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?